Skip to main content
. 2020 Jun 15;17(12):4279. doi: 10.3390/ijerph17124279

Figure 1.

Figure 1

Schematic representation for pathogenicity of novel coronavirus disease (CoVID-19) in humans. The viral transmission through human-to-human induces systemic effects and targets lungs causing clinical manifestation of symptoms associated with the virus that have been persistent in patients affected with CoVID-19. The pharmacological and non-pharmacological intervention strategies may mitigate these effects and assist in viral containment.